JoyceDFingerothMD
Infectious Disease • Worcester, MAAssociate Professor of Medicine, Beth Israel Deaconess Medical Center
Dr. Fingeroth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
119 Belmont St
Worcester, MA 01605Phone+1 508-334-5214
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1977 - 1980
New York University School of MedicineClass of 1977
Certifications & Licensure
MA State Medical License 1980 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 666 citationsEpstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Joyce D. Fingeroth, Janis J. Weis, Thomas F. Tedder, Jack L. Strominger, P A Biro
Proceedings of the National Academy of Sciences of the United States of America. 1984-07-01 - 282 citationsStructure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.Gordon J. Freeman, Gary S. Gray, Claude D. Gimmi, David B. Lombard, Liang Ji Zhou
The Journal of Experimental Medicine. 1991-09-01 - 202 citationsA phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.Susan P. Perrine, Olivier Hermine, Trudy N. Small, Felipe Suarez, Richard J. O'Reilly
Blood. 2007-03-15
Press Mentions
New Clues to Epstein-Barr VirusFebruary 21st, 2013
Grant Support
- Formins (FHOS) In Cd21-Mediated Signaling &Virus EntryNational Institute Of Allergy And Infectious Diseases2005–2009
- The Structural Basis Of EBV Attachment: CD21 &Gp350/220National Institute Of Dental &Craniofacial Research2004–2005
- Treatment Of Virus Associated Proliferative DisordersNational Cancer Institute1999–2003
- Design Of Ebvtk Substrates To Eradicate EBV+ TumorsNational Cancer Institute2001
- Pathogenesis Of Oral Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1999–2001
- Human Herpesvirus 8 Infection Of Dermal Microvascular Endothelial CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999
- Pathogenesis Of Oral Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1997–1998
- Putative Murine Complement Receptor Type 2National Institute Of Allergy And Infectious Diseases1988–1992
- Cloning &Characterization Of The EBV (C3D) ReceptorNational Cancer Institute1988
- Cloning And Characterization Of The EBV (C3D) ReceptorNational Cancer Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
